In this scenario, the response of cancer cells mediated largely by a group of stress-response proteins like RBM3 plays a crucial role in deciding the fate of cancer cells in the tumor microenvironment; that is “to be or not to be”. This evidence concerns the gene RBM3 and neoplasm.